Bioconjugated Nanometals and Cancer Therapy: A Pharmaceutical Perspective

References

• World Health Organization . Latest global cancer data: cancer burden rises to 18.1million new cases and 9.6 million cancer deaths in 2018. Press release 263 (2018).
   Google Scholar
• Gulf News . Cancer cases to double by 2030 in Middle East. https://gulfnews.com/uae/health/cancer-cases-to-double-by-2030-in-middle-east-1.2215775 (2018)
   Google Scholar
• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 68(6), 394–424 (2018).
   Google Scholar
• Jiang T , JinK, LiuX, PangZ. Nanoparticles for tumor targeting. In: Biopolymer-based composites.JanaS, MaitiS, JanaS ( Eds). Woodhead Publishing, Cambridge, UK, 221–267 (2017).
   Google Scholar
• Hasan S . A review on nanoparticles: their synthesis and types. Res. J. Recent. Sci.4( ISC-2014), 9–11 (2015).
   Google Scholar
• Prado-López S , González-BallesterosN, CarmenRodríguez-Argüelles M. Nanometals in cancer diagnosis and therapy. In: Biomaterials in Clinical Practice.ZivicF, AffatatoS, TrajanovicM, SchnabelrauchM, GrujovicN, ChoyKW ( Eds). Springer, Cham, Switzerland, 407–428 (2018).
   Google Scholar
• Bamrungsap S , ZhaoZ, ChenTet al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine (Lond.)7(8), 1253–1271 (2012).
   PubMed Web of Science ®Google Scholar
• Vinci G , RapaM. Noble metal nanoparticles applications: recent trends in food control. Bioengineering (Basel)6(1), 10 (2019).
   PubMedGoogle Scholar
• Raja M , ArasiAG, RaoMG, AnandhiB. Noble metal nanoparticles in cancer therapy: properties challenges and clinical applications. Int. J. Adv. Res.5(9), 127–135 (2017).
   Google Scholar
• Davis ME , ChenZG, ShinDM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug. Discov.7(9), 771–782 (2008).
   PubMed Web of Science ®Google Scholar
• Xue X , WangF, LiuX. Emerging functional nanomaterials for therapeutics. J. Mater. Chem.21(35), 13107–13127 (2011).
   Web of Science ®Google Scholar
• Fratoddi I , CartoniA, VendittiIet al. Gold nanoparticles functionalized by rhodamine B isothiocyanate: a new tool to control plasmonic effects. J. Colloid. Interface Sci.513, 10–19 (2018).
   PubMed Web of Science ®Google Scholar
• Nel A , XiaT, MädlerL, LiN. Toxic potential of materials at the nanolevel. Science311(5761), 622–627 (2006).
   PubMed Web of Science ®Google Scholar
• Sakhno O , YezhovP, HrynV, RudenkoV, SmirnovaT. Optical and nonlinear properties of photonic polymer nanocomposites and holographic gratings modified with noble metal nanoparticles. Polymers (Basel)12(2), 480 (2020).
   PubMed Web of Science ®Google Scholar
• Wu M , HuangS. Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. Mol. Clin. Oncol.7(5), 738–746 (2017).
   PubMed Web of Science ®Google Scholar
• Samanta A , MedintzIL. Nanoparticles and DNA – a powerful and growing functional combination in bionanotechnology. Nanoscale8(17), 9037–9095 (2016).
   PubMed Web of Science ®Google Scholar
• Graczyk A , PawlowskaR, JedrzejczykD, ChworosA. Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery. Molecules25(1), 204 (2020).
   PubMed Web of Science ®Google Scholar
• Conde J , DoriaG, BaptistaP. Noble metal nanoparticles applications in cancer. J. Drug. Deliv.2012, 751075 (2012).
   PubMedGoogle Scholar
• Yeh YC , CreranB, RotelloVM. Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale4(6), 1871–1880 (2012).
   PubMed Web of Science ®Google Scholar
• Gurunathan S , LeeKJ, KalishwaralalK, SheikpranbabuS, VaidyanathanR, EomSH. Antiangiogenic properties of silver nanoparticles. Biomaterials30(31), 6341–6350 (2009).
   PubMed Web of Science ®Google Scholar
• Asharani PV , HandeMP, ValiyaveettilS. Anti-proliferative activity of silver nanoparticles. BMC Cell. Biol.10, 65 (2009).
   PubMed Web of Science ®Google Scholar
• Rai M , IngleAP, BirlaS, YadavA, SantosCA. Strategic role of selected noble metal nanoparticles in medicine. Crit. Rev. Microbiol.42(5), 696–719 (2016).
   PubMed Web of Science ®Google Scholar
• Iravani S , KorbekandiH, MirmohammadiSV, ZolfaghariB. Synthesis of silver nanoparticles: chemical, physical and biological methods. Res. Pharm. Sci.9(6), 385–406 (2014).
   PubMedGoogle Scholar
• Stensberg MC , WeiQ, MclamoreES, PorterfieldDM, WeiA, SepulvedaMS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond.)6(5), 879–898 (2011).
   PubMed Web of Science ®Google Scholar
• Long NV , ChienND, HayakawaT, HirataH, LakshminarayanaG, NogamiM. The synthesis and characterization of platinum nanoparticles: a method of controlling the size and morphology. Nanotechnology21(3), 035605 (2010).
   PubMed Web of Science ®Google Scholar
• Manikandan M , HasanN, WuHF. Platinum nanoparticles for the photothermal treatment of Neuro 2A cancer cells. Biomaterials34(23), 5833–5842 (2013).
   PubMed Web of Science ®Google Scholar
• Shoshan MS , VonderachT, HattendorfB, WennemersH. Peptide-coated platinum nanoparticles with selective toxicity against liver cancer cells. Angew. Chem. Int. Ed. Engl.58(15), 4901–4905 (2019).
   PubMed Web of Science ®Google Scholar
• Pedone D , MoglianettiM, DeLuca E, BardiG, PompaPP. Platinum nanoparticles in nanobiomedicine. Chem. Soc. Rev.46(16), 4951–4975 (2017).
   PubMed Web of Science ®Google Scholar
• Zeng X , SunJ, LiSet al. Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent. Nat. Commun.11(1), 567 (2020).
   PubMed Web of Science ®Google Scholar
• Szalay B , TatraiE, NyiroG, VezerT, DuraG. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J. Appl. Toxicol.32(6), 446–453 (2012).
   PubMed Web of Science ®Google Scholar
• Wu W , HeQ, JiangC. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale. Res. Lett.3(11), 397–415 (2008).
   PubMed Web of Science ®Google Scholar
• Moacă E-A , CoricovacED, SoicaCM, PinzaruIA, PăcurariuCS, DeheleanCA. Preclinical aspects on magnetic iron oxide nanoparticles and their interventions as anticancer agents: enucleation, apoptosis and other mechanism. In: Iron Ores and Iron Oxide Materials.SharokhaV ( Ed.). IntechOpen, London, UK (2018).
   Google Scholar
• NDong C , TateJA, KettWCet al. Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo. PLoS ONE10(2), e0115636 (2015).
   PubMed Web of Science ®Google Scholar
• Yang X , LiQ, MengX, LiD. Evolution of nonlinear optical characteristics of magnetic nanoparticle colloidal suspensions after laser-induced clusters. ACS Omega5(26), 15821–15827 (2020).
   PubMed Web of Science ®Google Scholar
• Canalle LA , LöwikDWPM, Janvan Hest JCM. Polypeptide–polymer bioconjugates (critical review). Chem. Soc. Rev.39, 329–353 (2010).
   PubMed Web of Science ®Google Scholar
• Lee JJ , SaifulYazan L, CheAbdullah CA. A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment. Int. J. Nanomedicine2017(12), 2373–2384 (2017).
   Google Scholar
• Werengowska-Ciećwierz K , WiśniewskiM, TerzykA, FurmaniakS. The chemistry of bioconjugation in nanoparticles-based drug delivery system. Adv. Condens. Matter Phys.2015, 198175 (2015).
   Web of Science ®Google Scholar
• Sperling RA , ParakWJ. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos. Trans. A. Math. Phys. Eng. Sci.368(1915), 1333–1383 (2010).
   PubMed Web of Science ®Google Scholar
• Fraire JC , CoronadoEA. Design of plasmonic probes through bioconjugation and their applications in biomedicine: from cellular imaging to cancer therapy. In: Nanobiomaterials in Medical Imaging.GrumezescuAM ( Ed.). William Andrew Publishing, NY, USA, 131–161 (2016).
   Google Scholar
• Saboktakin M . Polyethylene glycol – Indocyanine green nanoparticles for photodynamic therapy technique. JSMC Nanotechnol. Nanomed.3, 6 (2019).
   Google Scholar
• Jokerst JV , LobovkinaT, ZareRN, GambhirSS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond.)6(4), 715–728 (2011).
   PubMed Web of Science ®Google Scholar
• Medina-Ramirez I , Gonzalez-GarciaM, PalakurthiJ, LiuS. Application of nanometals fabricated using green synthesis in cancer diagnosis and therapy. In: Green Chemistry. Environmentally Benign Approaches.MishraNK, KidwaiM ( Eds). IntechOpen, London, UK, 33–62 (2012).
   Google Scholar
• Ingram RS , HostetlerMJ, MurrayRW. Poly-hetero-ö-functionalized alkanethiolate-stabilized gold cluster compounds. J. Am. Chem. Soc.119(39), 9175–9178 (1997).
   Web of Science ®Google Scholar
• Wilhelma C , BilloteyC, RogerJ, PonsJN, BacriJC, GazeauF. Gazeaua. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials24(6), 1001–1011 (2003).
   PubMed Web of Science ®Google Scholar
• Gao X , YangL, PetrosJA, MarshallFF, SimonsJW, NieS. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol.16(1), 63–72 (2005).
   PubMed Web of Science ®Google Scholar
• Vashist SK . Comparison of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide based strategies to crosslink antibodies on amine-functionalized platforms for immunodiagnostic applications. Diagnostics (Basel)2(3), 23–33 (2012).
   PubMedGoogle Scholar
• Nobs L , BucheggerF, GurnyR, AllémannE. Current methods for attaching targeting ligands to liposomes and nanoparticles. J. Pharm. Sci.93(8), 1980–1992 (2004).
   PubMed Web of Science ®Google Scholar
• Zimmermann JL , NicolausT, NeuertG, BlankK. Thiol-based, site-specific and covalent immobilization of biomolecules for single-molecule experiments. Nat. Protoc.5(6), 975–985 (2010).
   PubMed Web of Science ®Google Scholar
• Spicer CD , PashuckET, StevensMM. Achieving controlled biomolecule-biomaterial conjugation. Chem. Rev.118(16), 7702–7743 (2018).
   PubMed Web of Science ®Google Scholar
• Alalaiwe A . The clinical pharmacokinetics impact of medical nanometals on drug delivery system. Nanomedicine17, 47–61 (2019).
   PubMed Web of Science ®Google Scholar
• Hurst SJ , Lytton-JeanAK, MirkinCA. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem.78(24), 8313–8318 (2006).
   PubMed Web of Science ®Google Scholar
• Chen S , YangK, TuguntaevRGet al. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine12(2), 269–286 (2016).
   PubMed Web of Science ®Google Scholar
• Suk JS , XuQ, KimN, HanesJ, EnsignLM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug. Deliv. Rev.99(Pt A), 28–51 (2016).
   PubMed Web of Science ®Google Scholar
• Van Vlerken LE , VyasTK, AmijiMM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm. Res.24(8), 1405–1414 (2007).
   PubMed Web of Science ®Google Scholar
• Gref R , MinamitakeY, PeracchiaMT, TrubetskoyV, TorchilinV, LangerR. Biodegradable long-circulating polymeric nanospheres. Science263(5153), 1600–1603 (1994).
   PubMed Web of Science ®Google Scholar
• Kanaras AG , KamounahFS, SchaumburgK, KielyCJ, BrustM. Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters. Chem. Commun. (Camb.)20, 2294–2295 (2002).
   PubMed Web of Science ®Google Scholar
• Mishra P , BismitaN, DeyRK. PEGylation in anti-cancer therapy: an overview. Asian J. Pharm. Sci.11(3), 337–348 (2015).
   Web of Science ®Google Scholar
• Shanmuganathan R , EdisonT, LewisoscarF, KumarP, ShanmugamS, PugazhendhiA. Chitosan nanopolymers: an overview of drug delivery against cancer. Int. J. Biol. Macromol.130, 727–736 (2019).
   PubMed Web of Science ®Google Scholar
• Li J , CaiC, LiJet al. Chitosan-based nanomaterials for drug delivery. Molecules23(10), 2661 (2018).
   PubMed Web of Science ®Google Scholar
• Ho DK , FrischS, BiehlAet al. Farnesylated glycol chitosan as a platform for drug delivery: synthesis, characterization, and investigation of mucus-particle interactions. Biomacromolecules19(8), 3489–3501 (2018).
   PubMed Web of Science ®Google Scholar
• Arias LS , PessanJP, VieiraAPM, LimaTMT, DelbemACB, MonteiroDR. Iron Oxide Nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics (Basel)7(2), 46 (2018).
   PubMed Web of Science ®Google Scholar
• Kim K , ChoiH, ChoiES, ParkMH, RyuJH. Hyaluronic acid-coated nanomedicine for targeted cancer therapy. Pharmaceutics11(7), 301 (2019).
   PubMed Web of Science ®Google Scholar
• Sutradhar KB , AminML. Nanotechnology in cancer drug delivery and selective targeting. ISRN. Nanotechnology2014, 939378 (2014).
   Google Scholar
• Lu C , ZhangC, WangPet al. Light-free generation of singlet oxygen through manganese-thiophene nanosystems for pH-responsive chemiluminescence imaging and tumor therapy. Chem.6(9), 2314–2334 (2020).
   Web of Science ®Google Scholar
• Song G , KenneyM, ChenYSet al. Carbon-coated FeCo nanoparticles as sensitive magnetic-particle-imaging tracers with photothermal and magnetothermal properties. Nat. Biomed. Eng.4(3), 325–334 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Y , ShiL, YeZet al. Reactive oxygen correlated chemiluminescent imaging of a semiconducting polymer nanoplatform for monitoring chemodynamic therapy. Nano. Lett.20(1), 176–183 (2020).
   PubMed Web of Science ®Google Scholar
• Song G , ChenM, ZhangYet al. Janus iron oxides @ semiconducting polymer nanoparticle tracer for cell tracking by magnetic particle imaging. Nano. Lett.18(1), 182–189 (2018).
   PubMed Web of Science ®Google Scholar
• Song G , ZhengX, WangY, XiaX, ChuS, RaoJ. A magneto-optical nanoplatform for multimodality imaging of tumors in mice. ACS Nano.13(7), 7750–7758 (2019).
   PubMed Web of Science ®Google Scholar
• Liang Y , LiuJ, LiuT, YangX. Anti-c-Met antibody bioconjugated with hollow gold nanospheres as a novel nanomaterial for targeted radiation ablation of human cervical cancer cell. Oncol. Lett.14(2), 2254–2260 (2017).
   PubMed Web of Science ®Google Scholar
• Guo J , O’driscollCM, HolmesJD, RahmeK. Bioconjugated gold nanoparticles enhance cellular uptake: a proof of concept study for siRNA delivery in prostate cancer cells. Int. J. Pharm.509(1–2), 16–27 (2016).
   PubMed Web of Science ®Google Scholar
• Danesh NM , LavaeeP, RamezaniM, AbnousK, TaghdisiSM. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles. Int. J. Pharm.489(1–2), 311–317 (2015).
   PubMedGoogle Scholar
• Majidi FS , MohammadiE, MehraviB, NouriS, AshtariK, Neshasteh-RizA. Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375. Artif. Cells. Nanomed. Biotechnol.47(1), 2161–2170 (2019).
   PubMed Web of Science ®Google Scholar
• Abdalla MS , SharadaHM, MostafaKAet al. Therapeutic effect of antimyeloma antibodies conjugated with gold nanoparticles on the growth of myeloma cell line. Int. Multidiscip. Res. J.2(6), 64–70 (2012).
   Google Scholar
• Liu T , TianJ, ChenZet al. Anti-TROP2 conjugated hollow gold nanospheres as a novel nanostructure for targeted photothermal destruction of cervical cancer cells. Nanotechnology25(34), 345103 (2014).
   PubMed Web of Science ®Google Scholar
• Sun X , ZhangG, PatelD, StephensD, GobinAM. Targeted cancer therapy by immunoconjugated gold-gold sulfide nanoparticles using Protein G as a cofactor. Ann. Biomed. Eng.40(10), 2131–2139 (2012).
   PubMed Web of Science ®Google Scholar
• Centi S , TatiniF, RattoFet al. In vitro assessment of antibody-conjugated gold nanorods for systemic injections. J. Nanobiotechnol.12, 55 (2014).
   PubMed Web of Science ®Google Scholar
• Casanas Pimentel RG , RoblesBotero V, SanMartin Martinez E, GomezGarcia C, HinestrozaJP. Soybean agglutinin-conjugated silver nanoparticles nanocarriers in the treatment of breast cancer cells. J. Biomater. Sci. Polym. Ed.27(3), 218–234 (2016).
   PubMed Web of Science ®Google Scholar
• Raja G , JangYK, SuhJS, KimHS, AhnSH, KimTJ. Microcellular environmental regulation of silver nanoparticles in cancer therapy: a critical review. Cancers (Basel)12(3), 664 (2020).
   PubMed Web of Science ®Google Scholar
• Kaluzova M , BourasA, MachaidzeR, HadjipanayisCG. Targeted therapy of glioblastoma stem-like cells and tumor nonstem cells using cetuximab-conjugated iron-oxide nanoparticles. Oncotarget6(11), 8788–8806 (2015).
   PubMedGoogle Scholar
• Wang AZ , BagalkotV, VasilliouCCet al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem3(9), 1311–1315 (2008).
   PubMed Web of Science ®Google Scholar
• Yu MK , ParkJ, JeongYY, MoonWK, JonS. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery. Nanotechnology21(41), 415102 (2010).
   PubMed Web of Science ®Google Scholar
• Jalalian SH , TaghdisiSM, ShahidiHamedani Net al. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Eur. J. Pharm. Sci.50(2), 191–197 (2013).
   PubMed Web of Science ®Google Scholar
• Varshosaz J , HassanzadehF, AliabadiHS, KhoraskaniFR, MirianM, BehdadfarB. Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles. Int. J. Biol. Macromol.93(Pt A), 1192–1205 (2016).
   PubMedGoogle Scholar
• Dilnawaz F , SinghA, MohantyC, SahooSK. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials31(13), 3694–3706 (2010).
   PubMed Web of Science ®Google Scholar
• Santra S , KaittanisC, GrimmJ, PerezJM. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small5(16), 1862–1868 (2009).
   PubMed Web of Science ®Google Scholar
• Das M , MishraD, DhakPet al. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging. Small5(24), 2883–2893 (2009).
   PubMed Web of Science ®Google Scholar
• Hadjipanayis CG , MachaidzeR, KaluzovaMet al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res.70(15), 6303–6312 (2010).
   PubMed Web of Science ®Google Scholar
• Sonvico F , MornetS, VasseurSet al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug. Chem.16(5), 1181–1188 (2005).
   PubMed Web of Science ®Google Scholar
• Reddy GR , BhojaniMS, McconvillePet al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer. Res.12(22), 6677–6686 (2006).
   PubMed Web of Science ®Google Scholar
• Yu MK , KimD, LeeIH, SoJS, JeongYY, JonS. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Small7(15), 2241–2249 (2011).
   PubMed Web of Science ®Google Scholar
• Lin J , LiY, LiYet al. Drug/dye-loaded, multifunctional PEG-chitosan-iron oxide nanocomposites for methotraxate synergistically self-targeted cancer therapy and dual model imaging. ACS. Appl. Mater. Interfaces7(22), 11908–11920 (2015).
   PubMed Web of Science ®Google Scholar
• Yang X , HongH, GrailerJJet al. cRGD-functionalized, DOX-conjugated, and (6)(4)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials32(17), 4151–4160 (2011).
   PubMed Web of Science ®Google Scholar
• Gmeiner WH , GhoshS. Nanotechnology for cancer treatment. Nanotechnol. Rev.3(2), 111–122 (2015).
   PubMed Web of Science ®Google Scholar
• Navya PN , KaphleA, SrinivasSP, BhargavaSK, RotelloVM, DaimaHK. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano. Converg.6(1), 23 (2019).
   PubMed Web of Science ®Google Scholar
• Attia MF , AntonN, WallynJ, OmranZ, VandammeTF. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J. Pharm. Pharmacol.71(8), 1185–1198 (2019).
   PubMed Web of Science ®Google Scholar
• Riley MK , VermerrisW. Recent advances in nanomaterials for gene delivery-A review. Nanomaterials (Basel)7(5), 94 (2017).
   PubMedGoogle Scholar
• Anis HA . Gene therapy in the era of nanotechnology/a review of current data. J. Cancer. Prev. Curr. Res.10(1), 1–2 (2019).
   Google Scholar
• Son S , NamJ, KimJ, KimS, KimWJ. i-motif-driven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal ablation. ACS. Nano8(6), 5574–5584 (2014).
   PubMed Web of Science ®Google Scholar
• Estelrich J , BusquetsMA. Iron oxide nanoparticles in photothermal therapy. Molecules23(7), 1567 (2018).
   PubMed Web of Science ®Google Scholar
• Melamed JR , EdelsteinRS, DayES. Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. ACS. Nano9(1), 6–11 (2015).
   PubMed Web of Science ®Google Scholar
• Delaney GP , BartonMB. Evidence-based estimates of the demand for radiotherapy. Clin. Oncol. (R. Coll. Radiol.)27(2), 70–76 (2015).
   PubMed Web of Science ®Google Scholar
• Haume K , RosaS, GrelletSet al. Gold nanoparticles for cancer radiotherapy: a review. Cancer. Nanotechnol.7(1), 8 (2016).
   PubMedGoogle Scholar
• Chen HHW , KuoMT. Improving radiotherapy in cancer treatment: promises and challenges. Oncotarget8(37), 62742–62758 (2017).
   PubMedGoogle Scholar
• Libutti SK , PaciottiGF, ByrnesAAet al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res.16(24), 6139–6149 (2010).
   PubMed Web of Science ®Google Scholar
• Yurkiewicz IR , MufflyL, LiedtkeM. Inotuzumab ozogamicin: a CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Drug. Des. Devel. Ther.12, 2293–2300 (2018).
   PubMed Web of Science ®Google Scholar
• Norsworthy KJ , KoCW, LeeJEet al. FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33-positive acute myeloid leukemia. Oncologist23(9), 1103–1108 (2018).
   PubMed Web of Science ®Google Scholar
• Thiesen B , JordanA. Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia24(6), 467–474 (2008).
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K , UlrichF, NestlerDet al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol.103(2), 317–324 (2011).
   PubMed Web of Science ®Google Scholar
• Marill J , AnesaryNM, ZhangPet al. Hafnium oxide nanoparticles: toward an in vitro predictive biological effect? Radiat. Oncol. 9, 150 (2014).
   PubMed Web of Science ®Google Scholar
• Pottier A , BorghiE, LevyL. New use of metals as nanosized radioenhancers. Anticancer Res.34(1), 443–453 (2014).
   PubMedGoogle Scholar
• Bobo D , RobinsonKJ, IslamJ, ThurechtKJ, CorrieSR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm. Res.33(10), 2373–2387 (2016).
   PubMed Web of Science ®Google Scholar
• Rijal G , LiW. Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering. J. Biol. Eng.12, 20 (2018).
   PubMed Web of Science ®Google Scholar
• Conde J , DoriaG, BaptistaP. Noble metal nanoparticles applications in cancer. J. Drug. Deliv.2012, 751075 (2012).
   PubMedGoogle Scholar
• Ventola CL . Progress in nanomedicine: approved and investigational nanodrugs. P&T42(12), 742–755 (2017).
   PubMedGoogle Scholar
• Havel H , FinchG, StrodePet al. Nanomedicines: from bench to bedside and beyond. AAPS J.18(6), 1373–1378 (2016).
   PubMed Web of Science ®Google Scholar
• Wadhawan A , ChatterjeeM, SinghG. Present scenario of bioconjugates in cancer therapy: a review. Int. J. Mol. Sci.20(21), (2019).
   PubMed Web of Science ®Google Scholar
• Karlsson HL , ToprakMS, FadeelB. Toxicity of metal and metal oxide nanoparticles. In: Handbook on the Toxicology of Metals (4th Edition).NordbergGF, FowlerBA, NordbergM ( Eds). Academic Press, CA, USA, 75–112 (2015).
   Google Scholar
• Hossen S , HossainMK, BasherMK, MiaMNH, RahmanMT, UddinMJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J. Adv. Res.15, 1–18 (2019).
   PubMed Web of Science ®Google Scholar